TACC2 and gastric cancer: The two recurrent FGFR2 fusions were FGFR2-BICC1 in two cases of hepatobiliary cancers (Bonferroni’s post-test, P = 0.006) and FGFR2-TACC2 in one case each of breast and gastric cancers.